<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04793893</url>
  </required_header>
  <id_info>
    <org_study_id>EPristinaHospital</org_study_id>
    <nct_id>NCT04793893</nct_id>
  </id_info>
  <brief_title>Treatment of Residual Hypermetropic Refraction on Young Patients After LASIK Using Human Fresh Corneal Lenticule Implantation With ReLEX Smile Surgery</brief_title>
  <acronym>Relex-Smile</acronym>
  <official_title>Treatment of Residual Hypermetropic Refraction on Young Patients After LASIK Using Human Fresh Corneal Lenticule Implantation Using Relex Smile Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Eye Hospital Pristina Kosovo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Eye Hospital Pristina Kosovo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      LASIK (laser-assisted in situ keratomileusis) is a type of refractive surgery for correction&#xD;
      of myopia, hyperopia and astigmatism. Yet approximately 30% of operated patients have&#xD;
      symptoms like glare, halos, dry eyes and especially residual hypermetrop refractive errors.&#xD;
&#xD;
      Residual hypermetrop refractive errors are difficult to treat surgically, the current&#xD;
      treatment is Refractive Lens Implantation - risks are similar to those of cataract surgery&#xD;
      (endophthalmitis, loss of accommodation, etc.)&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The main problem at young patients post - LASIK after one year is residual refractive errors.&#xD;
&#xD;
      The method used in Eye Hospital is treatment with implantation of human fresh corneal&#xD;
      lenticule (min. -1.50D) taken from myopic patients in post - LASIK patients with residual&#xD;
      refractive error (min. +1.0D).&#xD;
&#xD;
        1. The flap of LASIK is lifted, cleaned and then the lenticule is gently inserted. The&#xD;
           fresh myopic lenticule is implanted under the guidance of corneal topography in young&#xD;
           patients with hypermetropic astigmatism residual refraction, according to the low K&#xD;
           value. In cases where astigmatism is not present the lenticule is positioned in central&#xD;
           position under the flap.&#xD;
&#xD;
        2. The flap of LASIK is not touched or lifted but using VisuMax femtosecond laser we&#xD;
           created the stromal pocket with diameter 8.0 mm (1 mm larger than the optical zone of&#xD;
           the donor lenticule) and cap thickness set to 140 μm from corneal surface and 4 mm&#xD;
           superior incision. Hinge position flap was set at 90° angle 50° and width 4 mm, side cut&#xD;
           angle 90°. The pocket was dissected using a blunt spatula washed with normal saline. The&#xD;
           lenticule was held with lenticule forceps and gently inserted into the pocket through&#xD;
           the 4 mm superior incision.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">January 8, 2019</start_date>
  <completion_date type="Anticipated">January 8, 2023</completion_date>
  <primary_completion_date type="Actual">January 8, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Increase of visual acuity</measure>
    <time_frame>12 months</time_frame>
    <description>Increase of visual acuity by reducing residual hypermetropy refractive errors using ReLex Smile (human fresh lenticule implantation) after LASIK.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Refractive Errors</condition>
  <arm_group>
    <arm_group_label>Treatment of residual hypermetropia refraction after LASIK</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The main problem at young patients post - LASIK after one year is residual hypermetropic refractive errors (especially accommodation problem) The method used in Eye Hospital is treatment with implantation of human fresh corneal lenticule (min. -1.50D) taken from myopic patients in post - LASIK patients with residual hypermetropic refractive error (min. +1.0D).&#xD;
The flap of LASIk is lifted,cleaned and then the lenticule gently inserted.The lenticule was positioned according the K2 values when is astigmatism residual refractive error.In cases where is not astigmatism the lenticule was positioned in central position under the flap.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ReLex Smile</intervention_name>
    <description>With the ReLex Smile the optical zone (lenticule diameter) and cap diameter are 6.5 and 7.5 mm respectively. After dissection of both anterior and posterior planes, the lenticule is extracted through 120 degree superior 3.5 mm incision and marked with a sterile marker (ViscotMedster).</description>
    <arm_group_label>Treatment of residual hypermetropia refraction after LASIK</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  residual hypermetropic refraction,&#xD;
&#xD;
          -  low visual acuity&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  active anterior segment pathology,&#xD;
&#xD;
          -  glaucoma,&#xD;
&#xD;
          -  retinae detachment,&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Eye Hospital Pristina</name>
      <address>
        <city>Pristina</city>
        <zip>10000</zip>
        <country>Kosovo</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Kosovo</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>March 5, 2021</study_first_submitted>
  <study_first_submitted_qc>March 9, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 11, 2021</study_first_posted>
  <last_update_submitted>August 29, 2021</last_update_submitted>
  <last_update_submitted_qc>August 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Eye Hospital Pristina Kosovo</investigator_affiliation>
    <investigator_full_name>Dr. Faruk Semiz</investigator_full_name>
    <investigator_title>Head of Ophthalmology Department</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Refractive Errors</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

